People who take popular heartburn drugs like Prevacid, Prilosec and Nexium are vulnerable to death from cardiovascular disease, chronic kidney disease and upper gastrointestinal cancer, according to new research published in The BMJ.

The U.S. FDA on May 29 granted Amarin’s Vascepa (icosapent ethyl) priority review for a supplemental indication that would state the medication reduces cardiovascular risk in addition to helping patients manage elevated triglyceride levels.

A population-based cohort study out of France has identified a link between the consumption of ultra-processed foods and CVD, with a higher intake of sweet and starchy snacks translating to increased risks for cardiovascular, coronary heart and cerebrovascular diseases.

It’s unnecessary to fast before a complete cholesterol test, according to new research, especially if the sole intention of that test is to determine a patient’s risk of future cardiovascular events.

A recent analysis of the COAPT trial, published this spring in the Journal of the American College of Cardiology, suggests patients with symptomatic heart failure (HF) and secondary mitral regurgitation (MR) might see better mental and physical outcomes if they’re treated with edge-to-edge transcatheter mitral valve repair (TMVR) in lieu of standard therapy.

Researchers have identified a new barrier to timely care for MI patients: a perceived inability to act that leaves them immobilized and unable to seek professional help, in some cases for an excess of 24 hours.

Smoking flavored e-cigarettes can have a detrimental effect on endothelial function, leaving e-cig users prone to poor vascular health and heart disease, researchers report in the June edition of the Journal of the American College of Cardiology.

Millennials in their mid-thirties are less healthy than Generation Xers were at the same age, a recent analysis by Blue Cross Blue Shield found—a gap driven largely by poorer mental, cardiovascular and endocrine health outcomes in the younger generation.